A propos du SIDA = About AIDSVANE, John.Cahiers du Mouvement universel de la responsabilité scientifique. 1988, Num 12, pp 55-59, issn 0297-7664, 5 p.Article

Studies on meloxicam (Mobic) - a cyclooxygenase inhibitor with selectivitytowards COX-2VANE, John R.British journal of rheumatology. 1996, Vol 35, issn 0263-7103, 79 p., SUP1Serial Issue

Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2ENGELHARDT, G.British journal of rheumatology. 1996, Vol 35, pp 4-12, issn 0263-7103, SUP1Article

A review of the clinical pharmacokinetics of meloxicamTÜRCK, D; ROTH, W; BUSCH, U et al.British journal of rheumatology. 1996, Vol 35, pp 13-16, issn 0263-7103, SUP1Article

International Conference on EndothelinVANE, John; MASAKI, Tomoh; VANHOUTTE, Paul M et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, 580 p.Conference Proceedings

A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hipLINDEN, B; DISTEL, M; BLUHMKI, E et al.British journal of rheumatology. 1996, Vol 35, pp 35-38, issn 0263-7103, SUP1Article

A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritisREGINSTER, J. Y; DISTEL, M; BLUHMKI, E et al.British journal of rheumatology. 1996, Vol 35, pp 17-21, issn 0263-7103, SUP1Article

Meloxicam in osteoarthritis : A 6-month, double-blind comparison with diclofenac sodiumHOSIE, J; DISTEL, M; BLUHMKI, E et al.British journal of rheumatology. 1996, Vol 35, pp 39-43, issn 0263-7103, SUP1Article

Second international conference on endothelin, University of Tsukuba, Japan, December 9-12, 1990VANE, John; MASAKI, Tomoh; BOTTING, Renia et al.Journal of cardiovascular pharmacology. 1991, Vol 17, issn 0160-2446, 531 p., SUP7Conference Proceedings

International conference on endothelinVANE, John; MASAKI, Tomoh; VANHOUTTE, Paul M et al.Journal of cardiovascular pharmacology. 1993, Vol 22, issn 0160-2446, 393 p., SUP8Conference Proceedings

Local tissue tolerability of meloxicam, a new NSAID : Indications for parenteral, dermal and mucosal administrationSTEI, P; KRUSS, B; WIEGLEB, J et al.British journal of rheumatology. 1996, Vol 35, pp 44-50, issn 0263-7103, SUP1Article

Endothelin-1 displaces [³H]nicardipine binding in sections of human renal arteryAMENTA, F; FERRANTE, F.Journal of cardiovascular pharmacology. 1993, Vol 22, pp S171-S173, issn 0160-2446, SUP8Conference Paper

Endothelium-dependent contractions to endothelin in the rat aorta are mediated by thromboxane A₂TADDEI, S; VANHOUTTE, P. M.Journal of cardiovascular pharmacology. 1993, Vol 22, pp S328-S331, issn 0160-2446, SUP8Conference Paper

Tolerability of multiple administration of intramuscular meloxicam : A comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritisGHOZLAN, P. R; BERNHARDT, M; VELICITAT, P et al.British journal of rheumatology. 1996, Vol 35, pp 51-55, issn 0263-7103, SUP1Article

Changes in endothelin-1, 6-Keto-PG-F_1α, and TX-B₂ in random pattern flapsINOUE, H; AIHARA, M; TOMIOKA, M et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 477-479Conference Paper

Application of magnetic resonance imaging for evaluation of the efficacy of SB 217242 in neointimal formationCHANDRA, S; SARKAR, S; ELLIOT, J. D et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 317-319Conference Paper

Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1TAKAYANAGI, R; LIU, W; ITO, T et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 62-63Conference Paper

Chronic effects of a novel, orally active Endothelin receptor antagonist, T-0201, in dogs with congestive heart failureOHNISHI, M; WADA, A; TSUTAMOTO, T et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 236-238Conference Paper

Contractile activity of endothelins and their precursors in human umbilical artery and vein : Identification of distinct endothelin-converting enzyme activitiesRIZZI, A; CALO, G; BATTISTINI, B et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 58-61Conference Paper

Differential modulation of the renal and myocardial endothelin system by Angiotensin II in vivo effects of chronic selective ET_A receptor blockadeBARTON, M; SHAW, S; D'USCIO, L. V et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 265-268Conference Paper

Distinct endothelin-B receptors mediate the effects of sarafotoxin S6c and IRL1620 in the ileumMIASIRO, N; KARAKI, H; PAIVA, A. C. M et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 175-178Conference Paper

Effect of diltiazem and verapamil on endothelin release by cultured human coronary smooth-muscle cells and endothelial cellsHAUG, C; VOISARD, R; BAUR, R et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 388-391Conference Paper

Effects of dual endothelin-converting enzyme/neutral endopeptidase inhibitors, CGS 26303 and CGS 26393, on lipopolysaccharide or interleukin-1β-stimulated release of endothelin from guinea pig tracheal epithelial cellsPELLETIER, S; BATTISTINI, B; JENG, A. Y et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 10-12Conference Paper

Effects of endothelin-induced nitric oxide on venous circulation and renal water-electrolyte handlingOTA, K; KIMURA, T; SHOJI, M et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 128-132Conference Paper

Effects of human plasma proteins on endothelin binding and functionWU-WONG, J. R; DIXON, D. B; OPGENORTH, T. J et al.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 1, pp 164-168Conference Paper